Beyond the Abstract - A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: A multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study, by Florian M.E. Wagenlehner, MD, PhD
BERKELEY, CA (UroToday.com) - The prostatitis syndrome is a remarkably prevalent condition, frequently seen by urologists, and with a high impact on life quality.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 UroToday International Journal Correspondence
Privacy Policy | © 2010 UroToday ® All Rights Reserved |
